Creso Pharma Limited
COPHF · OTC
12/31/2023 | 6/30/2023 | 12/31/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $56,638 | -$56,638 | -$25,623 | -$7,159 |
| Dep. & Amort. | -$2,466 | $2,466 | $1,794 | -$1,794 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $0 | $0 | $0 | $0 |
| Other Non-Cash | -$42,384 | $42,384 | $12,555 | -$10,606 |
| Operating Cash Flow | $11,788 | -$11,788 | -$11,275 | -$19,558 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$133 | -$180 | -$141 | -$207 |
| Net Acquisitions | -$1,013 | $1,245 | $164 | -$164 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $640 | -$640 | $344 | -$2,280 |
| Investing Cash Flow | -$506 | $425 | $366 | -$2,650 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,674 | $2,436 | $3,046 | $1,542 |
| Stock Issued | -$1,837 | $6,961 | $4,722 | $5,240 |
| Stock Repurch. | -$699 | $0 | $0 | -$622 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4,318 | $0 | $0 | -$117 |
| Financing Cash Flow | -$3,122 | $10,627 | $9,181 | $4,630 |
| Forex Effect | $21 | $0 | $0 | -$17 |
| Net Chg. in Cash | -$696 | $0 | $0 | -$5,796 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,388 | $1,423 | $3,172 | $7,184 |
| End Cash | $692 | $1,081 | $1,384 | $1,388 |
| Free Cash Flow | $3,515 | -$11,969 | -$11,415 | -$19,766 |